BIIB Performance: 44.6% Return (12 Months)

BIIB returned 44.6% over 12 months, outperforming the S&P 500 (32.1%). Volatility: 31.0%.

RS IBD 25.92
Top 68% in Peers
Volatility 31.0%
Top 6% in Peers
Total Return 12m 44.59%
Top 70% in Peers
RS Rating 66.24
Top 68% in Peers
P/E
P/E Trailing 20.2
P/E Forward 12.0
High / Low 52w
52 Week High 201.18 USD
52 Week Low 113.38 USD
Sentiment
VRO Trend Strength ±100 9.06
Buy Signal ±3 -0.42
Drawdowns 3y
Max Drawdown 64.35%
Mean Drawdown 37.30%
Compare performance with 200 peers in Biotechnology
12m Total Return: BIIB (44.6%) vs PEER ETF Total Return of Biogen versus broad market ETF SPY
5y Drawdown (Underwater) Chart 5 Year Drawdown / Underwater Chart for BIIB Performance: 44.6% Return (12 Months)

Top Performer in Biotechnology (5/200)

Short Term Performance
SYMBOL 1W 1M 3M
ERAS 14.59% 10.67% 371.63%
DNTH 7.61% 31.13% 136.19%
ORKA 23.84% 70.97% 111.76%
CNTA 43.84% 52.87% 74.91%
KOD 15.86% 56.88% 55.69%
BIIB -8.12% -6.78% -5.62%
Long Term Performance
SYMBOL 6M 12M 5Y
ABVX 37.84% 2184.32% 929.91%
ABVX 33.07% 1990.72% 407.51%
KOD 166.21% 1688.99% -64.63%
TNGX 167.68% 1497.64% 78.77%
ERAS 634.76% 1297.55% -1.78%
BIIB 11.87% 44.59% -35.14%
Overall Best Picks of Peer Group (GARP Metrics)
SYMBOL MCAP 1M 12M 5Y P/E P/E fwd PEG EPS stab EPS cagr
ROIV NASDAQ
Roivant Sciences		 20.3B -3.13% 201% 184% - - - 37.2% -14.4%
UTHR NASDAQ
United Therapeutics		 24.8B 17.0% 91.8% 179% 20.3 20.0 2.25 -2.20% -35.9%
DAWN NASDAQ
Day One Biopharmaceuticals		 2.22B 1.23% 206% -17.1% - - - 57.3% 49.0%
FOLD NASDAQ
Amicus Therapeutics		 4.53B 0.77% 102% 55.9% - 30.5 -0.18 83.6% 131%
GLUE NASDAQ
Monte Rosa Therapeutics		 1.37B -4.89% 318% -20.1% - 10.9 - 59.8% 43.8%
MIRM NASDAQ
Mirum Pharmaceuticals		 5.68B 11.5% 135% 403% - - - 84.0% 24.5%
KRYS NASDAQ
Krystal Biotech		 7.57B 3.20% 57.7% 254% 37.9 44.8 - 84.4% 26.5%
AUPH NASDAQ
Aurinia Pharmaceuticals		 2.08B 11.7% 111% 23.5% 7.54 22.7 - 63.8% 123%
STRO NASDAQ
Sutro Biopharma		 394M -5.30% 234% -88.7% - 8.96 - -29.4% -68.0%
PHARM AS
Pharming		 1.17B 7.74% 102% 28.1% - 100 - -4.20% -

Performance: BIIB vs S&P 500

Total Return vs S&P 500
PERIOD BIIB S&P 500 DIFFERENCE
1 Month -6.78% -1.73% -5.13%
3 Months -5.62% -4.49% -1.18%
6 Months 11.87% -1.33% 13.38%
12 Months 44.59% 32.14% 9.42%
5 Years -35.14% 72.70% -62.45%

BIIB Performance FAQ

Does BIIB outperform the market?

Yes, BIIB significantly outperforms the market. Over the past 12 months, BIIB returned 44.59% compared to 32.14% for the S&P 500.

What is the BIIB return over the last 12 months?

BIIB has returned 44.59% over the past 12 months, including dividends. Over 3 months the return was -5.62%, and over 5 years -35.14%.

How risky is BIIB?

BIIB has relatively low risk with a maximum drawdown of 64.35% over the past 3 years. The average drawdown is 37.30%.

BIIB vs Sectors (12m)

Sorted by outperformance. Positive = BIIB beats sector.

Relative Performance vs S&P Sectors
SECTOR ETF DIFFERENCE 12M
Consumer Staples XLP 35.1%
Health Care XLV 33.9%
Real Estate XLRE 30.9%
Financials XLF 29.7%
Consumer Discretionary XLY 22.9%
Consumer Discretionary XLY 22.9%
Communication Services XLC 15.1%
Materials XLB 11%
Industrials XLI 2.5%
Technology XLK -5.4%
Energy XLE -12.8%

BIIB vs Asset Classes (12m)

Relative Performance vs Major Asset Classes
ASSET CLASS ETF DIFFERENCE 12M
S&P 500 SPY 9.42%
Gold GLD -11.7%
Long-Term Bonds TLT 44%